# Alastair M. Thompson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alastair-m-thompson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 40,280 |
| Field | Breast Cancer Treatment Studies |
| h-index | 85 |
| i10-index | 297 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5027846283 |
| ORCID iD | 0000-0003-0604-7267 |
| Works | 706 |

## Researcher papers

- [Landscape of somatic mutations in 560 breast cancer whole-genome sequences](https://scholariq.org/papers/landscape-of-somatic-mutations-in-560-breast-cancer-whole-genome-sequences/)
- [70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer](https://scholariq.org/papers/70-gene-signature-as-an-aid-to-treatment-decisions-in-early-stage-breast-cancer/)
- [Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial](https://scholariq.org/papers/risk-adapted-targeted-intraoperative-radiotherapy-versus-whole-breast/)
- [Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1](https://scholariq.org/papers/metformin-promotes-antitumor-immunity-via-endoplasmic-reticulum-associated/)
- [Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement](https://scholariq.org/papers/accelerated-partial-breast-irradiation-executive-summary-for-the-update-of-an/)
- [The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)](https://scholariq.org/papers/the-comet-comparison-of-operative-versus-monitoring-and-endocrine-therapy-trial/)
- [Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study](https://scholariq.org/papers/association-of-dcis-size-and-margin-status-with-risk-of-developing-breast-cancer/)
- [Disease-specific survival outcomes for patients after locoregional treatment for ductal carcinoma <i>in situ</i>: observational cohort study](https://scholariq.org/papers/disease-specific-survival-outcomes-for-patients-after-locoregional-treatment-for/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.